Serum levels of fibronectin in obese and non-obese women with polycystic ovary syndrome
https://doi.org/10.14341/probl201662427-31
Abstract
Aim — to investigate serum level of fibronectin in obese and non-obese women with polycystic ovary syndrome (PCOS) as a marker of endothelial dysfunction, and the relationship of that factor to the endothelium-dependent dilatation and other risk factors for cardiovascular disease.
Material and methods. We study 62 women: 45 — with PCOS (23 obese women, 22 — non-obese) and 20 — a control group. Serum level of fibronectin was determined by ELISA. Endothelium-dependent dilatation was measured by test of Celermajer. Data was presented as mean ± SD.
Results. We found an elevation of serum level of fibronectin in obese women with PCOS compared to control (258,12±48,47 and 196,34±46,68 pmol/ml respectively; р<0,05), in non-obese women compared to control (227,62±35,36 and 196,34±46,68 pmol/ml respectively, р<0,05). Serum level of fibronectin in obese was higher than non-obese women (258,12±48,47 и 227,62±35,36 pmol/ml respectively, р<0,05). Also, there are a correlation between the serum levels of fibronectin and BMI, HOMA index, lipid metabolism, androgens in PCOS women obese and non-obese (p<0,05).
Conclusion. Serum level of fibronectin is elevated in obese and non-obese women with PCOS. Hyperandrogenemia, dyslipidemia, insulin resistence, obesity appears to be significant factor to contributing elevation of fibronectin. The revealed change of fibronectin could reflect an endothelial dysfunction in PCOS.
About the Author
Mogylnytska A. Liliya
Khmelnytsky regional hospital
Ukraine
MD, PhD
Competing Interests:
Ukraine
MD, PhD
Competing Interests:
References
1. Norman RJ, Dewailly D, Legro RS, Hickey TE. Polycystic ovary syndrome. Lancet. 2007;370(9588):685-697. doi: 10.1016/S0140-6736(07)61345-2
2. Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113(10):1148-1159. doi: 10.1111/j.1471-0528.2006.00990.x
3. Orio FJR, Palomba S, Spinelli L, et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab. 2004;89(8):3696-3701. doi: 10.1210/jc.2003-032049
4. Kelly CJ, Speirs A, Gould GW, et al. Altered vascular function in young women with polycystc ovary syndrome. J Clin Endocrinol Metab. 2002;87(2):742-746. doi: 10.1210/jcem.87.2.8199
5. Escobar-Morreale HF, Luque-Ramirez M, San Millan JL. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev. 2005;26(2):251-282. doi: 10.1210/er.2004-0004
6. Tzeng CR, Chang YC, Chang YC, et al. Cluster analysis of cardiovascular and metabolic risk factors in women of reproductive age. Fertil Steril. 2014;101(5):1404-1410. doi: 10.1016/j.fertnstert.2014.01.023
7. Hynes RO. Fibronectins. Sci. Am. 1986;254(6):42-51.
8. Tomasini-Johansson BR, Annis DS, Mosher DF. The N-terminal 70-kDa fragment of fibronectin binds to cell surface fibronectin assembly sites in the absence of intact fibronectin. Matrix Biol. 2006;25(5):282-293. doi: 10.1016/j.matbio.2006.02.002
9. Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-47.
10. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440-1447. doi: 10.1210/jcem-21-11-1440
11. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. doi: 10.1210/jcem.84.10.6079
12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419. doi: 10.1007/BF00280883
13. Muolokwu E, Sanchez J, Bercaw JL, et al. Paratubal cysts, obesity, and hyperandrogenism. J Pediatr Surg. 2011;46(11):2164-2167. doi: 10.1016/j.jpedsurg.2011.07.011
14. Yildiz BO, Azziz R, Androgen E. Androgen excess and PCOS Society. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the androgen excess and PCOS Society. Fertil Steril. 2010;94(2):690-693. doi: 10.1016/j.fertnstert.2009.03.058
15. Juonala M, Magnussen CG, Berenson GS, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365(20):1876-1885. doi: 10.1056/nejmoa1010112
16. Rossi B, Sukalich S, Droz J, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocr Metab. 2008;93(12):4780-4786. doi: 10.1210/jc.2008-1198
17. Toscani MK, Mario FM, Radavelli-Bagatini S, Spritzer PM. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome. Nutr Res. 2011;31(2):97-103. doi: 10.1016/j.nutres.2011.01.009
18. Amato MC, Vesco R, Vigneri E, et al. Hyperinsulinism and polycystic ovary ayndrome (PCOS): role of insulin clearance. J Endocrinol Invest. 2015;38(12):1319-1326. doi: 10.1007/s40618-015-0372-x
19. Wojciechowski P, Lipowska A, Rys P, et al. Impact of FTO genotypes on BMI and weight in polycystic ovary syndrome: a systematic review and metaanalysis. Diabetologia. 2012;55(10):2636-2645. doi: 10.1007/s00125-012-2638-6
20. Xu N, Kwon S, Abbott DH, et al. Epigenetic mechanism underlying the development of polycystic ovary syndrome (PCOS)-like phenotypes on prenatally androgenized rhesus monkeys. PLoS One. 2011;6(11):e27286. doi: 10.1371/journal.pone.0027286
21. Corbould A. Chronic testosterone treatment induces selective insulin resistance in subcutaneous adipocytes of women. J Endocrinol. 2007;192(3):585-594. doi: 10.1677/joe.1.07070
22. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet. 1992;340(8828):1111-1115. doi: 10.1016/0140-6736(92)93147-f
Supplementary files
Review
For citations:
Liliya M.A. Serum levels of fibronectin in obese and non-obese women with polycystic ovary syndrome. Problems of Endocrinology. 2016;62(4):27-31. (In Russ.) https://doi.org/10.14341/probl201662427-31
Views:
854
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
.jpg){kind=logo}
